Description
LHC-165 is a benzonaphthyridine TLR7 agonist.
Product Unit Size | Cost | Quantity | Stock |
---|
LHC-165 is a benzonaphthyridine TLR7 agonist.
Cas No. | 1258595-14-0 |
---|---|
Purity | ≥99% |
Formula | C29H32F2N3O7P |
Formula Wt. | 603.56 |
IUPAC Name | 3-[5-amino-2-[2-[4-[2-(3,3-difluoro-3-phosphonopropoxy)ethoxy]-2-methylphenyl]ethyl]benzo[f][1,7]naphthyridin-8-yl]propanoic acid |
Synonym | LHC165 |
Appearance | Pale yellow powder |
Store Temp | -20°C |
---|---|
Ship Temp | Ambient |
Info Sheet |
---|
Zawit M, Swami U, Awada H, et al. Current status of intralesional agents in treatment of malignant melanoma. Ann Transl Med. 2021 Jun;9(12):1038. PMID: 34277838
Pentacyclic triterpene.
Fermentation impurity
Sesquiterpene lactone found in Artemisia (wormw...
Flavanol found in Camilla (green tea); AhR ant...
Loratadine metabolite; FIASMA, histamine H1 ant...
Excitatory amino acid found in seaweed; AMPA an...
Protein translation inhibitor.
Antimicrobial peptide found in Apis mellifera.<...
Tyrosine kinase inhibitor.
Dual inhibitor of PI3K and mTOR.
Recombinant protein containing Treponema pallid...
Flavonoid found in fruits, vegetables, and grai...
AurKA inhibitor.
Oxazolidone derivative; Factor Xa inhibitor.
Nitroimidazole; hypoxic modifier and radiosensi...
CSF-1R Inhibitor.
Endogenous quaternary ammonium, required for fa...
Synthetic vitamin E, antioxidant.
Endogenous peptide hormone, involved in feeding...
Endogenous peptide hormone, involved in water h...